The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Recapitulating Pancreatic Tumor Microenvironment through Synergistic Use of Patient Organoids and Organ‐on‐a‐Chip Vasculature
Open accessAbstract
Tumor progression relies on the interaction between neoplastic epithelial cells and their surrounding stromal partners. This cell cross‐talk affects stromal development, and ultimately the heterogeneity impacts drug efficacy. To mimic this evolving paradigm, 3D vascularized pancreatic adenocarcinoma tissue is microengineered in a tri‐culture system composed of patient‐derived pancreatic organoids, human fibroblasts, and endothelial cells on a perfusable platform, situated in a 96‐well plate. Through synergistic engineering, the benefits of cellular fidelity of patient tumor organoids are combined with the flow control of an organ‐on‐a‐chip platform. Validation of this platform includes demonstrating the growth of pancreatic tumor organoids by monitoring the change in metabolic activity of the tissue. Investigation of the tumor microenvironment highlights the role of fibroblasts in symbiosis with patient organoids, resulting in a six‐fold increase of collagen deposition and corresponding increase in tissue stiffness in comparison to fibroblast free controls. The value of a perfusable vascular network is evident in drug screening, as perfusing gemcitabine into stiffened matrix does not show the dose‐dependent effects on decrease in tumor viability as those under static conditions. These findings demonstrate the importance of a dynamic synergistic relationship between patient cells with stromal fibroblasts, in a 3D perfused vascular network, to accurately recapitulate a dynamic tumor microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“they can emulate human (patho)physiology in a more human-like environment49,51,55–57.”
From Human disease models in drug development (2023) · cites this paper as [49]
The cited source says what the claim attributes to it.
In the citing paper
“This organoid-on-a-chip model may serve as a valuable tool for studying the interactions between cancer cells and the TME, providing a platform for personalized medicine in PDAC.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Lai et al., 2020
The cited source says what the claim attributes to it.
In the citing paper
“A recent study introduced a perfusable, 3D organoid-on-a-chip model to recapitulate the PDAC TME (Lai et al., 2020).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Lai et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Burris, H. A., Moore, M. J., Andersen, J., Green, M. R., Rothenberg, M. L., Modiano, M. R., Cripps, M. C., Portenoy, R. K., Storniolo, A. M., Tarassoff, P., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2403 · Cited by 5,894
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Organogenesis in a dish: Modeling development and disease using organoid technologies
Lancaster, M. A., & Knoblich, J. A. (2014) · Science · doi:10.1126/science.1247125 · Cited by 2,931
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162024 · Cited by 2,590
Ryan, D. P., Hong, T. S., & Bardeesy, N. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1404198 · Cited by 2,348
Organoid models of human and mouse ductal pancreatic cancer
Boj, S. F., Hwang, C.-I., Baker, L. A., Chio, I. I. C., Engle, D. D., Corbo, V., Jager, M., Ponz-Sarvise, M., Tiriac, H., Spector, M. S., et al. (2015) · Cell · doi:10.1016/j.cell.2014.12.021 · Cited by 2,150
Feig, C., Jones, J. O., Kraman, M., Wells, R. J. B., Deonarine, A., Chan, D. S., Connell, C. M., Roberts, E. W., Zhao, Q., Caballero, O. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320318110 · Cited by 2,100
Research works printed but not linked: 2
- Netti P. A., 2000, Cancer Res., 60, 2497
- Conze D., 2001, Cancer Res., 61, 8851
Cited by
Human disease models in drug development
Loewa, A., Feng, J. J., & Hedtrich, S. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00063-3 · Cited by 331
Organs-on-a-chip models for biological research
Vunjak-Novakovic, G., Ronaldson-Bouchard, K., & Radisic, M. (2021) · Cell · doi:10.1016/j.cell.2021.08.005 · Cited by 248
“…OOC devices are on the order of micrometers to millimeters in size, whereas regenerative engineering re-creates structures on the order of millimeters to centimeters. ll Review 2016), and tumors (Lai et al., 2020), all of which are being used to study tissue maturation, regeneration, and disease.”
BackgroundMethodInfluentialSelf-citationMicrofluidic organoids-on-a-chip: The future of human models
Saorin, G., Caligiuri, I., & Rizzolio, F. (2023) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2022.10.001 · Cited by 196
Integrating organoids and organ-on-a-chip devices
Zhao, Y., Landau, S., Okhovatian, S., Liu, C., Lu, R. X. Z., Lai, B. F. L., Wu, Q., Kieda, J., Cheung, K., Rajasekar, S., et al. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00207-z · Cited by 185
Self-citationPatient-derived pancreatic cancer-on-a-chip recapitulates the tumor microenvironment
Haque, M. R., Wessel, C. R., Leary, D. D., Wang, C., Bhushan, A., & Bishehsari, F. (2022) · Microsystems & Nanoengineering · doi:10.1038/s41378-022-00370-6 · Cited by 137
Harane, S. E., Zidi, B., Harane, N. E., Krause, K., Matthes, T., & Preynat‐Seauve, O. (2023) · Cells · doi:10.3390/cells12071001 · Cited by 154
Advances in Spheroids and Organoids on a Chip
Fang, G., Chen, Y., Lu, H., & Jin, D. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202215043 · Cited by 141
Xin, Y., Li, K., Huang, M. L., Liang, C., Siemann, D. W., Wu, L., Tan, Y., & Tang, X. (2023) · Oncogene · doi:10.1038/s41388-023-02844-x · Cited by 149
Lai, B. F. L., Lu, R. X. Z., Huyer, L. D., Kakinoki, S., Yazbeck, J., Wang, E. Y., Wu, Q., Zhang, B., & Radisic, M. (2021) · Nature Protocols · doi:10.1038/s41596-020-00490-1 · Cited by 114
Self-citationKim, S. K., Kim, Y. H., Park, S., & Cho, S. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.002 · Cited by 98
Organs-on-a-chip: a union of tissue engineering and microfabrication
Zhao, Y., Wang, E. Y., Lai, F. B. L., Cheung, K., & Radisic, M. (2023) · Trends in Biotechnology · doi:10.1016/j.tibtech.2022.12.018 · Cited by 93
Self-citationMicrofluidic high-throughput 3D cell culture
Ko, J., Park, D., Lee, J., Jung, S., Baek, K., Sung, K. E., Lee, J., & Jeon, N. L. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00163-8 · Cited by 88
New Strategy for Promoting Vascularization in Tumor Spheroids in a Microfluidic Assay
Wan, Z., Floryan, M. A., Coughlin, M. F., Zhang, S., Zhong, A. X., Shelton, S. E., Wang, X., Xu, C., Barbie, D. A., & Kamm, R. D. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202201784 · Cited by 84
4D printing: a cutting-edge platform for biomedical applications
Naniz, M. A., Askari, M., Zolfagharian, A., Naniz, M. A., & Bodaghi, M. (2022) · Biomedical Materials · doi:10.1088/1748-605x/ac8e42 · Cited by 86
Engineering Organ-on-a-Chip Systems for Vascular Diseases
Shakeri, A., Wang, Y., Zhao, Y., Landau, S., Perera, K., Lee, J., & Radisic, M. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.318233 · Cited by 96
Self-citationEmerging tumor-on-chips with electrochemical biosensors
Lei, L., Ma, B., Xu, C., & Liu, H. (2022) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2022.116640 · Cited by 72
Tumor-on-a-chip models combined with mini-tissues or organoids for engineering tumor tissues
Hwangbo, H., Chae, S., Kim, W.-J., Jo, S., & Kim, G. (2023) · Theranostics · doi:10.7150/thno.90093 · Cited by 73
Advances in Microfluidic Technologies in Organoid Research
Liu, H., Gan, Z., Qin, X., Wang, Y., & Qin, J. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202302686 · Cited by 73
Advancing Tissue Decellularized Hydrogels for Engineering Human Organoids
Moura, B. S., Monteiro, M. V., Ferreira, L. P., Lavrador, P., Gaspar, V. M., & Mano, J. F. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202202825 · Cited by 66
Engineering in vitro vascular microsystems
Liu, Q., Ying, G., Hu, C., Du, L., Zhang, H., Wang, Z., Yue, H., Yetisen, A. K., Wang, G., Shen, Y., et al. (2025) · Microsystems & Nanoengineering · doi:10.1038/s41378-025-00956-w · Cited by 71
Lu, R. X. Z., Lai, B. F. L., Rafatian, N., Gustafson, D., Campbell, S. B., Banerjee, A., Kozak, R., Mossman, K., Mubareka, S., Howe, K. L., et al. (2022) · Lab on a Chip · doi:10.1039/d1lc00817j · Cited by 58
Self-citationStrategies to overcome the limitations of current organoid technology - engineered organoids
Fan, X., Hou, K., Liu, G., Shi, R., Wang, W., & Liang, G. (2025) · Journal of Tissue Engineering · doi:10.1177/20417314251319475 · Cited by 77
Organoid Vascularization: Strategies and Applications
Gao, Q., Wang, J., Zhang, H., Wang, J., Jing, Y., & Su, J. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202500301 · Cited by 75
Advances in cardiac tissue engineering and heart‐on‐a‐chip
Kieda, J., Shakeri, A., Landau, S., Wang, E. Y., Zhao, Y., Lai, B. F., Okhovatian, S., Wang, Y., Jiang, R., & Radisic, M. (2023) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37633 · Cited by 56
Self-citationFluid flow to mimic organ function in 3D in vitro models
Juste-Lanas, Y., Hervás-Raluy, S., García‐Aznar, J. M., & González‐Loyola, A. (2023) · APL Bioengineering · doi:10.1063/5.0146000 · Cited by 55
Hu, Y., Zhu, T., Cui, H., & Cui, H. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202403762 · Cited by 57
Self-citationThe Revolutionary Roads to Study Cell–Cell Interactions in 3D In Vitro Pancreatic Cancer Models
Cave, D. D., Rizzo, R., Sáinz, B., Gigli, G., del Mercato, L. L., & Lonardo, E. (2021) · Cancers · doi:10.3390/cancers13040930 · Cited by 50
Cancer-on-a-chip for precision cancer medicine
Liu, L., Wang, H., Chen, R., Song, Y., Wei, W., Baek, D. S. H., Gillin, M., Kurabayashi, K., & Chen, W. (2025) · Lab on a Chip · doi:10.1039/d4lc01043d · Cited by 52
Regulation of Tumor Invasion by the Physical Microenvironment: Lessons from Breast and Brain Cancer
Beeghly, G. F., Amofa, K. Y., Fischbach, C., & Kumar, S. (2022) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-110220-115419 · Cited by 46
Vascularised organoids: Recent advances and applications in cancer research
Zhou, R., Brislinger, D., Fuchs, J., Lyons, A., Langthaler, S., Hauser, C. A. E., & Baumgartner, C. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70258 · Cited by 41
Engineering complexity in human tissue models of cancer
Ronaldson-Bouchard, K., Baldassarri, I., Tavakol, D. N., Graney, P. L., Samaritano, M., Cimetta, E., & Vunjak‐Novakovic, G. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114181 · Cited by 44
Cancer-on-chip: a 3D model for the study of the tumor microenvironment
Cauli, E., Polidoro, M. A., Marzorati, S., Bernardi, C., Rasponi, M., & Lleò, A. (2023) · Journal of Biological Engineering · doi:10.1186/s13036-023-00372-6 · Cited by 51
Patient‐Derived Microphysiological Systems for Precision Medicine
Ko, J., Song, J., Choi, N., & Kim, H. N. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202303161 · Cited by 46
Cancer Metastasis‐on‐a‐Chip for Modeling Metastatic Cascade and Drug Screening
Brooks, A., Zhang, Y., Chen, J., & Zhao, C. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202302436 · Cited by 43
Multi-organ-on-chip approach in cancer research
Żuchowska, A., & Skorupska, S. (2021) · Organs-on-a-Chip · doi:10.1016/j.ooc.2021.100014 · Cited by 46
Vascularized organoid-on-a-chip: design, imaging, and analysis
Yu, T., Yang, Q., Peng, B., Gu, Z., & Zhu, D. Y. (2024) · Angiogenesis · doi:10.1007/s10456-024-09905-z · Cited by 37
Organ-Chip Models: Opportunities for Precision Medicine in Pancreatic Cancer
Haque, M. R., Rempert, T. H., Al-Hilal, T. A., Wang, C., Bhushan, A., & Bishehsari, F. (2021) · Cancers · doi:10.3390/cancers13174487 · Cited by 46
Imaging 3D cell cultures with optical microscopy
Hsieh, H.-C., Han, Q., Brenes, D., Bishop, K. W., Wang, R., Wang, Y., Poudel, C., Glaser, A. K., Freedman, B., Vaughan, J. C., et al. (2025) · Nature Methods · doi:10.1038/s41592-025-02647-w · Cited by 49
On-chip modeling of tumor evolution: Advances, challenges and opportunities
Li, C., Holman, J. B., Shi, Z., Qiu, B., & Ding, W. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100724 · Cited by 39
In situ biosensing technologies for an organ-on-a-chip
Kim, J., Kim, J., Jin, Y., & Cho, S. (2023) · Biofabrication · doi:10.1088/1758-5090/aceaae · Cited by 36
Mallya, D., Gadre, M. A., Varadharajan, S., & Vasanthan, K. S. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1457872 · Cited by 38
Kalla, J., Pfneissl, J., Mair, T., Tran, L., & Egger, G. (2024) · Cellular Oncology · doi:10.1007/s13402-024-00960-8 · Cited by 33
Viscoelastic hydrogels for interrogating pancreatic cancer-stromal cell interactions
Lin, F., Chang, C., Nguyen, H. D., Li, H., Fishel, M. L., & Lin, C. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100576 · Cited by 28
Breast cancer immune microenvironment: from pre-clinical models to clinical therapies
Wilson, B. E., Gorrini, C., & Cescon, D. W. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06431-0 · Cited by 31
Synthetic developmental biology: Engineering approaches to guide multicellular organization
Zarkesh, I., Ashtiani, M. K., Shiri, Z., Aran, S., Braun, T. W., & Baharvand, H. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.02.004 · Cited by 27
Microfluidic Droplet-Assisted Fabrication of Vessel-Supported Tumors for Preclinical Drug Discovery
Wu, Y., Zhao, Y., Zhou, Y., Islam, K., & Liu, Y. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c23305 · Cited by 26
Technological Advances in Tumor-On-Chip Technology: From Bench to Bedside
Bērziņa, S., Harrison, A., Taly, V., & Xiao, W. (2021) · Cancers · doi:10.3390/cancers13164192 · Cited by 29
Elastomeric Polyesters in Cardiovascular Tissue Engineering and Organs-on-a-Chip
Okhovatian, S., Shakeri, A., Huyer, L. D., & Radisic, M. (2023) · Biomacromolecules · doi:10.1021/acs.biomac.3c00387 · Cited by 30
Self-citationBioengineering Approaches for the Pancreatic Tumor Organoids Research and Application
Song, T., Kong, B., Liu, R., Luo, Y., Wang, Y., & Zhao, Y. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202300984 · Cited by 24
Conte, M., & Cauda, V. (2022) · Advanced Therapeutics · doi:10.1002/adtp.202200079 · Cited by 29
Cardiac organoid: multiple construction approaches and potential applications
Yang, Z., Zhang, Y., Wang, J., Yin, J., Wang, Z., & Pei, R. (2023) · Journal of Materials Chemistry B · doi:10.1039/d3tb00783a · Cited by 26
Landon‐Brace, N., Li, N. T., & McGuigan, A. P. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202300903 · Cited by 27
Tanaka, H. Y., Nakazawa, T., Miyazaki, T., Cabral, H., Masamune, A., & Kano, M. R. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.03.041 · Cited by 26
Vascularized tumor models for the evaluation of drug delivery systems: a paradigm shift
Lopez-Vince, E., Wilhelm, C., & Simón‐Yarza, T. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01580-3 · Cited by 26
Bioengineering vascularization
Landau, S., Okhovatian, S., Zhao, Y., Liu, C., Shakeri, A., Wang, Y., Ramsay, K., Kieda, J., Jiang, R., & Radisic, M. (2024) · Development · doi:10.1242/dev.204455 · Cited by 30
Self-citationEngineering CAR‐T Therapeutics for Enhanced Solid Tumor Targeting
Zhu, D., Kim, W., Lee, H., Bao, X., & Kim, P. (2025) · Advanced Materials · doi:10.1002/adma.202414882 · Cited by 32
Mei, X., Yang, Z., Wang, X., Shi, A., Blanchard, J., Elahi, F. M., Kang, H., Orive, G., & Zhang, Y. S. (2025) · Lab on a Chip · doi:10.1039/d4lc00280f · Cited by 27
Geyer, M., & Queiroz, K. C. S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.761807 · Cited by 23
Organoid‐based precision medicine in pancreatic cancer
Beutel, A. K., Ekizce, M., Ettrich, T. J., Seufferlein, T. T. W., Lindenmayer, J., Gout, J., & Kleger, A. (2024) · United European Gastroenterology Journal · doi:10.1002/ueg2.12701 · Cited by 26
Zhou, L., Liu, L., Chang, M. A., Ma, C., Chen, W., & Chen, P. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115064 · Cited by 22
Revealing the clinical potential of high-resolution organoids
Ko, J., Hyung, S., Cheong, S., Chung, Y., & Jeon, N. L. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115202 · Cited by 24
Modelling and breaking down the biophysical barriers to drug delivery in pancreatic cancer
Kpeglo, D., Haddrick, M., Knowles, M. A., Evans, S. D., & Peyman, S. A. (2024) · Lab on a Chip · doi:10.1039/d3lc00660c · Cited by 22
Lim, J., Fang, H., Bupphathong, S., Sung, P.-C., Yeh, C.-E., Huang, W. R., & Lin, C.-H. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c01978 · Cited by 23
Deipenbrock, A., Wilmes, B. E., Sommermann, T. G., Abdo, N., Moustakas, K., Raasch, M., Rennert, K., & Teusch, N. E. (2025) · Lab on a Chip · doi:10.1039/d4lc01016g · Cited by 22
Engineering of biomaterials for tumor modeling
Choi, S. R., Yang, Y., Huang, K., Kong, H., Flick, M. J., & Han, B. (2020) · Materials Today Advances · doi:10.1016/j.mtadv.2020.100117 · Cited by 23
Gayibov, E., Sychra, T., Spálenková, A., Souček, P., & Oliverius, M. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117750 · Cited by 25
Advances in bioengineering pancreatic tumor-stroma physiomimetic Biomodels
Monteiro, M. V., Ferreira, L. P., Rocha, M., Gaspar, V. M., & Mano, J. F. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121653 · Cited by 19
Gaebler, D., Hachey, S. J., & Hughes, C. C. W. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1462293 · Cited by 22
Pancreatic organoids as cancer avatars for true personalized medicine
Gout, J., Ekizce, M., Roger, É., & Kleger, A. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115642 · Cited by 22
Lee, J., Jung, S., Hong, H. K., Jo, H., Rhee, S., Jeong, Y., Ko, J., Cho, Y. B., & Jeon, N. L. (2024) · Lab on a Chip · doi:10.1039/d3lc01055d · Cited by 18
PDAC-on-chip for in vitro modeling of stromal and pancreatic cancer cell crosstalk
Sgarminato, V., Marasso, S. L., Cocuzza, M., Scordo, G., Ballesio, A., Ciardelli, G., & Tonda-Turo, C. (2023) · Biomaterials Science · doi:10.1039/d2bm00881e · Cited by 17
Mai, S., & Inkielewicz‐Stępniak, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021066 · Cited by 21
The challenge of making the right choice: patient avatars in the era of cancer immunotherapies
Kayser, C., Bräuer, A., Susanne, S., & Wandmacher, A. M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1237565 · Cited by 17
Dubrova, A., Cavaniol, C., de Walle, A. V., Mathieu, P., Fusilier, Z., Yaacoub, N., Lalatonne, Y., Descroix, S., & Wilhelm, C. (2025) · ACS Nano · doi:10.1021/acsnano.5c02099 · Cited by 17
Strelez, C., Perez, R. G., Chlystek, J. S., Cherry, C., Yoon, A. Y., Haliday, B., Shah, C. A., Ghaffarian, K., Sun, R., Jiang, H., et al. (2023) · SSRN Electronic Journal · doi:10.1101/2023.09.14.557797 · Cited by 19
Patient-derived organoids as a model for tumor research
Wang, J., Feng, X., Li, Z., Chen, Y., & Huang, W. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.03.004 · Cited by 19
Building Blood Vessel Chips with Enhanced Physiological Relevance
Mu, X., Gerhard‐Herman, M. D., & Zhang, Y. S. (2023) · Advanced Materials Technologies · doi:10.1002/admt.202201778 · Cited by 16
Progress and application of lung-on-a-chip for lung cancer
Li, L., Bo, W., Wang, G., Juan, X., Xue, H., & Zhang, H. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1378299 · Cited by 18
Payne, M. C., Ho, S. Y., Hashimoto, T., Imboden, S., Diaz, J. A., Lee, B. S., Rupert, M. J., Cai, N., Goldstein, A. S., & Lin, N. Y. C. (2023) · Biotechnology Journal · doi:10.1002/biot.202200434 · Cited by 12
Organoids as an Enabler of Precision Immuno-Oncology
Zhao, J., Fong, A. S. W., Seow, S. V., & Toh, H. C. (2023) · Cells · doi:10.3390/cells12081165 · Cited by 13
Advanced in vitro models for renal cell carcinoma therapy design
Mieville, V., Griffioen, A. W., Benamran, D. A., & Nowak-Sliwinska, P. M. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188942 · Cited by 17
Melzer, M. K., Breunig, M., Arnold, F., Wezel, F., Azoitei, A., Roger, É., Krüger, J., Merkle, J., Schütte, L. D., Resheq, Y. J., et al. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202102345 · Cited by 19
Microphysiological systems as models for immunologically ‘cold’ tumors
Gaebler, D., Hachey, S. J., & Hughes, C. C. W. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1389012 · Cited by 14
Cadavid, J. L., Li, N. T., & McGuigan, A. P. (2024) · Biophysics Reviews · doi:10.1063/5.0179125 · Cited by 12
Mohan, M. D., Latifi, N., Flick, R., Simmons, C. A., & Young, E. W. K. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c00556 · Cited by 19
3D in vitro modeling of the exocrine pancreatic unit using tomographic volumetric bioprinting
Sgarminato, V., Madrid-Wolff, J. A., Boniface, A., Ciardelli, G., Tonda‐Turo, C., & Moser, C. (2024) · Biofabrication · doi:10.1088/1758-5090/ad6d8d · Cited by 15
Nasiri, R., Madadelahi, M., Nikmaneshi, M. R., Gökçe, B., Bijarchi, M. A., Shah, S., Tirpáková, Z., Gastel, D. V., Taebnia, N., de Barros, N. R., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123739 · Cited by 19
Reconstitution of human tissue barrier function for precision and personalized medicine
Kim, J., Yoon, T., Lee, S. W., Kim, P. J., & Kim, Y. (2024) · Lab on a Chip · doi:10.1039/d4lc00104d · Cited by 16
Aksoy, S. A., Earl, J., Grahovac, J., Karakaş, D., Lencioni, G., Sığırlı, S., & Bijlsma, M. F. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.12.003 · Cited by 11
Gu, L., Liu, P., Zhao, W. Y., Fan, Y., Wang, Y., & Chen, P. (2025) · MedMat. · doi:10.1097/mm9.0000000000000016 · Cited by 12
Developing organs-on-chips for biomedicine
Zhu, Y., Cai, L., Chen, H., & Zhao, Y. (2022) · 中国科学通报:英文版 · doi:10.1016/j.scib.2022.04.012 · Cited by 12
Applications and challenges of patient-derived organoids in hepatobiliary and pancreatic cancers
Hu, J.-W., Pan, Y., Zhang, X., Li, J., & Jin, Y. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i20.106747 · Cited by 10
Sun, Y., Liu, J., Zhu, L., Huang, F., Dong, Y., Liu, S., Chen, S., Ji, W., Lu, J., Liu, L., et al. (2025) · Bioengineering · doi:10.3390/bioengineering12020146 · Cited by 12
Self-citationCellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC
Musiu, C., Lupo, F., Agostini, A., Lionetto, G., Bevere, M., Paiella, S., Carbone, C., Corbo, V., Ugel, S., & Sanctis, F. D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1341079 · Cited by 10
Application and development of Organ-on-a-Chip technology in cancer therapy
Wang, L. X., Liu, S. L., & Wu, N. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1643230 · Cited by 14
State-matched organoid models to fight pancreatic cancer
Melzer, M. K., Roger, É., & Kleger, A. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.03.003 · Cited by 9
The application of pancreatic cancer organoids for novel drug discovery
Melzer, M. K., Resheq, Y. J., Navaee, F., & Kleger, A. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2194627 · Cited by 9
Advancements and challenges in culturing patient-derived cancer cells for personalized therapeutics
Fu, Y., Khoo, B. L., & Lim, C. T. (2025) · Frontiers in Lab on a Chip Technologies · doi:10.3389/frlct.2025.1663420 · Cited by 10
Personalized Models of Biological Barriers and Their Diseases: Recent Progress with Organs‐On‐Chips
Buck, F., Bugter, J., Yorukoglu, G., Dastjerd, M. K., & Winkler, T. E. (2026) · Advanced Biology · doi:10.1002/adbi.202500536 · Cited by 10
Li, T., Yang, Y., Yang, F., Li, Y., Qiao, H., Yan, Y., & Ding, X. (2025) · Cell Biology International · doi:10.1002/cbin.70067 · Cited by 6
Metadata
- Authors
- Lai, B. F. L., Lu, R. X. Z., Hu, Y., Davenport Huyer, L., Dou, W., Wang, E. Y., Radulovich, N., Tsao, M. S., Sun, Y., & Radisic, M.
- Affiliations
- University of Toronto (CA)
- Institute of Biomaterials and Biomedical Engineering University of Toronto Toronto Ontario Canada
- University Health Network (CA)
- Corresponding author
- Radisic, Milica
- ORCID
- Venue
- Advanced Functional Materials
- Publisher
- Wiley
- Published
- 2020-06-08
- Volume
- 30
- Issue
- 48
- ISSN
- 1616-301X (ISSN-L)
- 1616-3028
- PMC
- PMC7939064
- OpenAlex
- W3035635204
- Cited by
- 142
- References
- 91
- Citations by year
- 2026: 22 · 2025: 29 · 2024: 32 · 2023: 32 · 2022: 17 · 2021: 9 · 2020: 1
- FWCI
- 4.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Advanced Functional Materials (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Canadian Institutes of Health Research (MOP‐126027, MOP‐137107, MOP‐142382, FDN‐167274)
- Natural Sciences and Engineering Research Council of Canada (RGPIN 326982‐10)
- National Science Foundation (2R01 HL076485)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- pancreatic ductal adenocarcinoma, tumor microenvironment, organ-on-a-chip, perfusable vascular networks, stromal fibroblasts, collagen deposition, tissue stiffness, 3D tissue engineering
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.